172 related articles for article (PubMed ID: 31453359)
21. Systematic overview of cost-utility assessments in oncology.
Earle CC; Chapman RH; Baker CS; Bell CM; Stone PW; Sandberg EA; Neumann PJ
J Clin Oncol; 2000 Sep; 18(18):3302-17. PubMed ID: 10986064
[TBL] [Abstract][Full Text] [Related]
22. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
Allen D; Gillen E; Rixson L
JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
[TBL] [Abstract][Full Text] [Related]
23. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
[TBL] [Abstract][Full Text] [Related]
24. Systematic searching and selection of health state utility values from the literature.
Papaioannou D; Brazier J; Paisley S
Value Health; 2013 Jun; 16(4):686-95. PubMed ID: 23796303
[TBL] [Abstract][Full Text] [Related]
25. The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation.
Picot J; Copley V; Colquitt JL; Kalita N; Hartwell D; Bryant J
Health Technol Assess; 2015 Aug; 19(69):1-190. PubMed ID: 26323045
[TBL] [Abstract][Full Text] [Related]
26. Investigation of Evidence Sources for Health-Related Quality of Life in Cost-Utility Analysis of Pharmaceuticals in Japan.
Azuma MK; Ikeda S
Value Health Reg Issues; 2014 May; 3():190-196. PubMed ID: 29702927
[TBL] [Abstract][Full Text] [Related]
27. Physical activity in advanced cancer patients: a systematic review protocol.
Lowe SS; Tan M; Faily J; Watanabe SM; Courneya KS
Syst Rev; 2016 Mar; 5():43. PubMed ID: 26968701
[TBL] [Abstract][Full Text] [Related]
28. Many Miles to Go: A Systematic Review of the State of Cost-Utility Analyses in Brazil.
Campolina AG; Rozman LM; Decimoni TC; Leandro R; Novaes HM; De Soárez PC
Appl Health Econ Health Policy; 2017 Apr; 15(2):163-172. PubMed ID: 27798797
[TBL] [Abstract][Full Text] [Related]
29. The cost-effectiveness of oral health interventions: A systematic review of cost-utility analyses.
Hettiarachchi RM; Kularatna S; Downes MJ; Byrnes J; Kroon J; Lalloo R; Johnson NW; Scuffham PA
Community Dent Oral Epidemiol; 2018 Apr; 46(2):118-124. PubMed ID: 28925508
[TBL] [Abstract][Full Text] [Related]
30. Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review.
Clegg A; Bryant J; Nicholson T; McIntyre L; De Broe S; Gerard K; Waugh N
Health Technol Assess; 2001; 5(1):1-137. PubMed ID: 11262420
[TBL] [Abstract][Full Text] [Related]
31. Health State Utility Values in Juvenile Idiopathic Arthritis: What is the Evidence?
Grazziotin LR; Currie G; Kip MMA; IJzerman MJ; Twilt M; Lee R; Marshall DA
Pharmacoeconomics; 2020 Sep; 38(9):913-926. PubMed ID: 32390065
[TBL] [Abstract][Full Text] [Related]
32. Trends in the measurement of health utilities in published cost-utility analyses.
Brauer CA; Rosen AB; Greenberg D; Neumann PJ
Value Health; 2006; 9(4):213-8. PubMed ID: 16903990
[TBL] [Abstract][Full Text] [Related]
33. A Systematic Review of Health State Utility Values in the Plastic Surgery Literature.
Christopher AN; Morris MP; Patel V; Klifto K; Fischer JP
Plast Reconstr Surg Glob Open; 2021 Nov; 9(11):e3944. PubMed ID: 34849317
[TBL] [Abstract][Full Text] [Related]
34. Cost-Effectiveness of Treatment Options for Neuropathic Pain: a Systematic Review.
Ruiz-Negrón N; Menon J; King JB; Ma J; Bellows BK
Pharmacoeconomics; 2019 May; 37(5):669-688. PubMed ID: 30637713
[TBL] [Abstract][Full Text] [Related]
35. EQ-5D-Derived Health State Utility Values in Hematologic Malignancies: A Catalog of 796 Utilities Based on a Systematic Review.
Golicki D; Jaśkowiak K; Wójcik A; Młyńczak K; Dobrowolska I; Gawrońska A; Basak G; Snarski E; Hołownia-Voloskova M; Jakubczyk M; Niewada M
Value Health; 2020 Jul; 23(7):953-968. PubMed ID: 32762998
[TBL] [Abstract][Full Text] [Related]
36. Digital Education for the Management of Chronic Wounds in Health Care Professionals: Protocol for a Systematic Review by the Digital Health Education Collaboration.
Martinengo L; Yeo NJY; Tang ZQ; Markandran KD; Kyaw BM; Tudor Car L
JMIR Res Protoc; 2019 Mar; 8(3):e12488. PubMed ID: 30907743
[TBL] [Abstract][Full Text] [Related]
37. A systematic review of economic evaluations in second and later lines of therapy for the treatment of non-small cell lung cancer.
Jäkel A; Plested M; Dharamshi K; Modha R; Bridge S; Johns A
Appl Health Econ Health Policy; 2013 Feb; 11(1):27-43. PubMed ID: 23329379
[TBL] [Abstract][Full Text] [Related]
38. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.
Papaioannou D; Rafia R; Rathbone J; Stevenson M; Buckley Woods H; Stevens J
Health Technol Assess; 2012; 16(37):1-253, iii-iv. PubMed ID: 23021127
[TBL] [Abstract][Full Text] [Related]
39. Growth and quality of the cost-utility literature, 1976-2001.
Neumann PJ; Greenberg D; Olchanski NV; Stone PW; Rosen AB
Value Health; 2005; 8(1):3-9. PubMed ID: 15841889
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]